Investment Thesis
Harrow demonstrates strong top-line growth (36.4% YoY) with healthy gross margins (61.2%), but operates deeply in the red with negative operating cash flow (-$9M) and a dangerously overleveraged balance sheet (10.45x debt-to-equity). The company is burning cash operationally despite revenue growth, creating unsustainable balance sheet risk given minimal equity cushion of just $28.7M against $300M in debt.
Strengths
- Strong revenue growth of 36.4% year-over-year
- Healthy gross margin of 61.2% indicates product viability
- Adequate cash reserves of $94.6M providing short-term runway
Risks
- Severe operating losses with -50% operating margin and -$27.6M net loss on $44.2M revenue
- Negative operating cash flow of -$9M indicating the business is not self-sustaining at current scale
- Extreme leverage of 10.45x debt-to-equity with minimal equity ($28.7M) against $300M debt creating acute distress risk
Key Metrics to Watch
- Operating cash flow trajectory and path to positive OCF
- Operating margin improvement toward breakeven
- Debt-to-equity ratio reduction and deleveraging progress
Financial Metrics
Revenue
44.2M
Net Income
-27.6M
EPS (Diluted)
$-0.74
Free Cash Flow
-9.2M
Total Assets
419.5M
Cash
94.6M
Profitability Ratios
Gross Margin
61.2%
Operating Margin
-50.0%
Net Margin
-62.4%
ROE
-96.2%
ROA
-6.6%
FCF Margin
-20.8%
Balance Sheet & Liquidity
Current Ratio
2.48x
Quick Ratio
2.30x
Debt/Equity
10.45x
Debt/Assets
93.2%
Interest Coverage
-4.08x
Long-term Debt
300.0M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-13T08:37:24.742535 |
Data as of: 2026-03-31 |
Powered by Claude AI